FOLFIRINOX Improves PFS Compared with Gemcitabine in Patients with Locally Advanced Pancreatic Carcinoma By Ogkologos - May 26, 2025 479 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PRODIGE 29-UCGI 26 (NEOPAN) study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Niraparib / Abiraterone Acetate Lisocabtagene Maraleucel Shows Deep, Durable Responses in Patients with Relapsed or Refractory MZL After at Least Two Previous Lines of Systemic Therapy New ESMO Local and Locoregional Prostate Cancer Living Guideline v1.0 MOST POPULAR ESMO Immuno-Oncology Congress 2022, 7-9 December, Geneva, Switzerland November 29, 2022 New Radiation Therapy Won’t Leave Breast Cancer Patients with Unwanted Tattoo... September 13, 2019 Taking Time for the Everyday Things in 2024 December 29, 2023 FDA Grants Accelerated Approval to Dostarlimab-gxly for dMMR Advanced Solid Tumours August 20, 2021 Load more HOT NEWS Firefighter Advocates For Men’s Health While He Battles Breast Cancer In... 2021 ASCO Annual Meeting Research Round Up: Advances in Treating Lung... Research Says That Your Birth Order Can Shape Your Personality Taking Time for the Everyday Things in 2024
